How may a pharma factory become a partner in the development of drugs and nutraceuticals?

Wednesday March 8
Business workshop: Biotech to business – Strategies for success
09:40

How may a pharma factory become a partner in the development of drugs and nutraceuticals?

Leif Rune Skymoen, CEO
Curida AS, Norway

The use of Contract Development and Manufacturing Organisations (CDMOs) is a trend in the international pharmaceutical and neutraceutical industry. CDMOs offer a broader range of services than traditional pharma manufacturers, which mainly perform large-scale, commercial production. CDMO services typically include product formulation, development of analytical methods, stability controls, selection of packaging materials, regulatory support, and product supply for clinical trials. Early partnering with a CDMO can therefore be an important factor in ensuring a rapid and successful development path for new neutraceuticals and pharmaceutical products.